Research / LYB / Fundamental state Inspectable configuration
State dimensions Filing 0001489393-23-000037 General Corporate
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.97% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.71% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-30.29% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
51.19% · OPTIONAL · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
9.96% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.32% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.24% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 3.49%
Current 2.97%
Delta -0.53% Cash Generation Increased
Previous 4.78%
Current 12.71%
Delta 7.93% Growth Decreased
Previous -21.53%
Current -30.29%
Delta -8.76% Inventory Pressure Decreased
Previous 51.19%
Current 51.19%
Delta -0.00% Profitability Increased
Previous 7.08%
Current 9.96%
Delta 2.89% R And D Intensity Decreased
Previous 0.33%
Current 0.32%
Delta -0.01% Sbc Intensity Decreased
Previous 0.24%
Current 0.24%
Delta -0.00% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.